Interinvest has obviously taken a very keen interest in Tyhee. Their financial support and board representation has been invaluble in boosting the confidence of ALL shareholders. No doubt it will continue to bode us well as we gear up for production.

So who is Interinvest? I was curious also...so I just did a few Googles.

In the words of their Chairman, Dr. Hans Black: "In many ways, the goals of medicine and money management are remarkably similar: our orientation towards the preservation of principal, first and foremost, equates to the Hippocratic oath, Do No Harm."

Interinvest occupies a suite on the third floor of this building in the leather district of Boston, MA. 192 South Street. Interinvest Corp. has approximately $38 million in assets under management. The firm provides its services to individuals. It also manages accounts for pension and profit sharing plans, charitable organizations, corporations, and state or municipal government entities. It invests in the public equity and debt markets of the United States. The firm invests in micro-cap, small-cap, mid-cap, and large-cap companies. It invests in value stocks selected on the basis of a top down stock picking approach. The firm invests in high quality short-term securities on the basis of a top down approach for its debt investments. Interinvest Corp., Inc. was founded in 1975 and is based in Boston, Massachusetts. The firm has additional offices in Montreal, Canada; Hamilton, Bermuda; and Zurich, Switzerland.

Interinvest is 100% privately owned. Mr. Black, as seen in this video, has a worldly grasp on what is going on with global economies. In this video from 2008 he called the bottom on General Electric and Wells Fargo. He serves as Chairman of the Board on SoYummi Inc. He came to the rescue of a Montreal high school acquaintence and at the same time became an equity partner in her now successful soy based company. Incidently, SoYummi and Interinvest Consulting share the same address in Montreal. So does Interconinvest and Reuters Canada (but I doubt this is of any importance to Tyhee shareholders.) There was an issue with some disgruntled investors a few years back but this has already been discussed here and again, is not worth bringing up IMHO.

In 2010, Interinvest Inc.'s Chairman sold the majority of his shares in Angiotech when he felt actions of the company was diluting it's share value. This bodes well for the interest of Tyhee shareholders. The last thing we want to see also is dilution of OUR shares.

I believe Interinvest has and will continue to provide the funds necessary for keeping Tyhee a veritable investment. My confidence remains high that we are in good hands.